June 09, 2009
Article
CURE chooses the winning essay for it 2009 Extraordinary Healer Award for Oncology Nursing.
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC